BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29373718)

  • 1. The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma.
    Aldave G; Gonzalez-Huarriz M; Rubio A; Romero JP; Ravi D; Miñana B; Cuadrado-Tejedor M; García-Osta A; Verhaak R; Xipell E; Martinez-Vélez N; de la Rocha AA; Puigdelloses M; García-Moure M; Marigil M; Gállego Pérez-Larraya J; Marín-Bejar O; Huarte M; Carro MS; Ferrarese R; Belda-Iniesta C; Ayuso A; Prat-Acín R; Pastor F; Díez-Valle R; Tejada S; Alonso MM
    Neuro Oncol; 2018 Jun; 20(7):930-941. PubMed ID: 29373718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTBP1-dependent regulation of USP5 alternative RNA splicing plays a role in glioblastoma tumorigenesis.
    Izaguirre DI; Zhu W; Hai T; Cheung HC; Krahe R; Cote GJ
    Mol Carcinog; 2012 Nov; 51(11):895-906. PubMed ID: 21976412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SON drives oncogenic RNA splicing in glioblastoma by regulating PTBP1/PTBP2 switching and RBFOX2 activity.
    Kim JH; Jeong K; Li J; Murphy JM; Vukadin L; Stone JK; Richard A; Tran J; Gillespie GY; Flemington EK; Sobol RW; Lim SS; Ahn EE
    Nat Commun; 2021 Sep; 12(1):5551. PubMed ID: 34548489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression.
    Ferrarese R; Harsh GR; Yadav AK; Bug E; Maticzka D; Reichardt W; Dombrowski SM; Miller TE; Masilamani AP; Dai F; Kim H; Hadler M; Scholtens DM; Yu IL; Beck J; Srinivasasainagendra V; Costa F; Baxan N; Pfeifer D; von Elverfeldt D; Backofen R; Weyerbrock A; Duarte CW; He X; Prinz M; Chandler JP; Vogel H; Chakravarti A; Rich JN; Carro MS; Bredel M
    J Clin Invest; 2014 Jul; 124(7):2861-76. PubMed ID: 24865424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
    Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
    Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma.
    Zhang S; Wei JS; Li SQ; Badgett TC; Song YK; Agarwal S; Coarfa C; Tolman C; Hurd L; Liao H; He J; Wen X; Liu Z; Thiele CJ; Westermann F; Asgharzadeh S; Seeger RC; Maris JM; Guidry Auvil JM; Smith MA; Kolaczyk ED; Shohet J; Khan J
    Cancer Lett; 2016 Feb; 371(2):214-24. PubMed ID: 26683771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines.
    Cheung HC; Hai T; Zhu W; Baggerly KA; Tsavachidis S; Krahe R; Cote GJ
    Brain; 2009 Aug; 132(Pt 8):2277-88. PubMed ID: 19506066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircSMARCA5 Inhibits Migration of Glioblastoma Multiforme Cells by Regulating a Molecular Axis Involving Splicing Factors SRSF1/SRSF3/PTB.
    Barbagallo D; Caponnetto A; Cirnigliaro M; Brex D; Barbagallo C; D'Angeli F; Morrone A; Caltabiano R; Barbagallo GM; Ragusa M; Di Pietro C; Hansen TB; Purrello M
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM.
    Xie R; Chen X; Chen Z; Huang M; Dong W; Gu P; Zhang J; Zhou Q; Dong W; Han J; Wang X; Li H; Huang J; Lin T
    Cancer Lett; 2019 May; 449():31-44. PubMed ID: 30742945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation and functional significance of CDC42 alternative splicing in ovarian cancer.
    He X; Yuan C; Yang J
    Oncotarget; 2015 Oct; 6(30):29651-63. PubMed ID: 26336992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suggestive evidence on the involvement of polypyrimidine-tract binding protein in regulating alternative splicing of MAP/microtubule affinity-regulating kinase 4 in glioma.
    Fontana L; Rovina D; Novielli C; Maffioli E; Tedeschi G; Magnani I; Larizza L
    Cancer Lett; 2015 Apr; 359(1):87-96. PubMed ID: 25578778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of PTBP1 promote invasion of colorectal cancer by alternative splicing of cortactin.
    Wang ZN; Liu D; Yin B; Ju WY; Qiu HZ; Xiao Y; Chen YJ; Peng XZ; Lu CM
    Oncotarget; 2017 May; 8(22):36185-36202. PubMed ID: 28404950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTBP1 enhances exon11a skipping in Mena pre-mRNA to promote migration and invasion in lung carcinoma cells.
    Li S; Shen L; Huang L; Lei S; Cai X; Breitzig M; Zhang B; Yang A; Ji W; Huang M; Zheng Q; Sun H; Wang F
    Biochim Biophys Acta Gene Regul Mech; 2019 Aug; 1862(8):858-869. PubMed ID: 31075540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTBP1 is a Novel Poor Prognostic Factor for Glioma.
    Liu P; He GC; Tan YZ; Liu GX; Liu AM; Zhu XP; Zhou Y; Hu WM
    Biomed Res Int; 2022; 2022():7590997. PubMed ID: 35299889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia induced LUCAT1/PTBP1 axis modulates cancer cell viability and chemotherapy response.
    Huan L; Guo T; Wu Y; Xu L; Huang S; Xu Y; Liang L; He X
    Mol Cancer; 2020 Jan; 19(1):11. PubMed ID: 31964396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients with Non-muscle-Invasive Bladder Cancer.
    Bielli P; Panzeri V; Lattanzio R; Mutascio S; Pieraccioli M; Volpe E; Pagliarulo V; Piantelli M; Giannantoni A; Di Stasi SM; Sette C
    Clin Cancer Res; 2018 Nov; 24(21):5422-5432. PubMed ID: 30012566
    [No Abstract]   [Full Text] [Related]  

  • 17. N
    Ji X; Liu Z; Gao J; Bing X; He D; Liu W; Wang Y; Wei Y; Yin X; Zhang F; Han M; Lu X; Wang Z; Liu Q; Xin T
    Cell Death Differ; 2023 Jan; 30(1):54-68. PubMed ID: 35871232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA-binding proteins RBM20 and PTBP1 regulate the alternative splicing of FHOD3.
    Lorenzi P; Sangalli A; Fochi S; Dal Molin A; Malerba G; Zipeto D; Romanelli MG
    Int J Biochem Cell Biol; 2019 Jan; 106():74-83. PubMed ID: 30468920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A developmentally regulated spliced variant of PTBP1 is upregulated in type 1 diabetic hearts.
    Belanger K; Nutter CA; Li J; Yu P; Kuyumcu-Martinez MN
    Biochem Biophys Res Commun; 2019 Feb; 509(2):384-389. PubMed ID: 30594394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA splicing analysis deciphers developmental hierarchies and reveals therapeutic targets in adult glioma.
    Song X; Tiek D; Miki S; Huang T; Lu M; Goenka A; Iglesia R; Yu X; Wu R; Walker M; Zeng C; Shah H; Weng SHS; Huff A; Zhang W; Koga T; Hubert C; Horbinski CM; Furnari FB; Hu B; Cheng SY
    J Clin Invest; 2024 Apr; 134(11):. PubMed ID: 38662454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.